科斯莫斯健康的Cur18补充剂旨在在一年半内为美国带来250万美元收入. Cosmos Health's Cur18 supplement aims to generate $2.5 million in U.S. revenue within a year and a half.

全球医疗保健公司Cosmos Health预计其新的基于黄素的补充剂, Cur18, 将在12至18个月内为美国带来超过250万美元的年收入. Global healthcare company Cosmos Health projects its new curcumin-based supplement, Cur18, will generate over $2.5 million in incremental annual revenue in the U.S. within 12 to 18 months. 该产品的推出是按阶段战略进行,从直接向消费者提供电子商务开始,依据内部销售假设和市场条件. The product launches in a phased strategy starting with direct-to-consumer e-commerce, relying on internal sales assumptions and subject to market conditions.